The L-Type Amino Acid Transporter LAT1—An Emerging Target in Cancer

Транспортер аминокислот L-типа LAT1 — перспективная мишень при раке
Pascal Häfliger, Roch‐Philippe Charles
2019-05-16

L-type amino acid transporter LAT1SLC7A5canceressential amino acid uptaketherapeutic target
Chronic proliferation is a major hallmark of tumor cells. Rapidly proliferating cancer cells are highly dependent on nutrients in order to duplicate their cell mass during each cell division. In particular, essential amino acids are indispensable for proliferating cancer cells. Their uptake across the cell membrane is tightly controlled by membrane transporters. Among those, the L-type amino acid transporter LAT1 (SLC7A5) has been repeatedly found overexpressed in a vast variety of cancers. In this review, we summarize the most recent advances in our understanding of the role of LAT1 in cancer and highlight preclinical studies and drug developments underlying the potential of LAT1 as therapeutic target.
1
LAT1 (SLC7A5) is a membrane transporter that tightly regulates amino-acid uptake in cancer cells.
2
LAT1 is repeatedly reported to be overexpressed across a wide variety of cancers.
3
Rapidly proliferating cancer cells depend on essential amino acids to duplicate cell mass during each division.
4
Recent preclinical studies and drug-development efforts support LAT1 as a potential therapeutic target in oncology.
5
The review summarizes advances in understanding LAT1’s role in cancer and evaluates its therapeutic potential.

L-type amino acid transporter LAT1 (SLC7A5) in cancer cells

LAT1 overexpression, role in cancer cell amino acid uptake and proliferation, and its potential as a therapeutic target

Publication Details
Publication Date
2019-05-16
Journal
Publisher
ISSN
Cited by
232
Access Type
Author Information
Authors
Pascal Häfliger
Roch‐Philippe Charles
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%